Cohen, E. Suzanne http://orcid.org/0000-0002-4470-1680
Scott, Ian C.
Majithiya, Jayesh B.
Rapley, Laura
Kemp, Benjamin P.
England, Elizabeth
Rees, D. Gareth
Overed-Sayer, Catherine L.
Woods, Joanne
Bond, Nicholas J.
Veyssier, Christel Séguy
Embrey, Kevin J.
Sims, Dorothy A.
Snaith, Michael R.
Vousden, Katherine A.
Strain, Martin D.
Chan, Denice T. Y.
Carmen, Sara
Huntington, Catherine E.
Flavell, Liz
Xu, Jianqing
Popovic, Bojana
Brightling, Christopher E.
Vaughan, Tristan J.
Butler, Robin
Lowe, David C.
Higazi, Daniel R.
Corkill, Dominic J.
May, Richard D.
Sleeman, Matthew A.
Mustelin, Tomas
Article History
Received: 9 March 2015
Accepted: 11 August 2015
First Online: 14 September 2015
Competing interests
: C.E.B. has received research support and consultancy fees from GSK, MedImmune, BI, Novartis, Roche, and Chiesi and has received travel support from BI, the European Respiratory Society, and the American Thoracic Society. The remaining authors are employees of the AstraZeneca Group and have stock/stock options in AstraZeneca.